Orlandi, A., Salvatori, F., Sacco, L., Arcuri, G., Pontolillo, L., Palazzo, A., Garufi, G., Mastrantoni, L., Monte, E. D., Maliziola, N., Rotondi, A., Frescura, V., Paris, I., Carbognin, L., Leone, A. D., Sanchez, A. M., Franceschini, G., Fabi, A., Bria, E., Tortora, G. (2026). Survival outcomes of neoadjuvant versus adjuvant chemotherapy in stage II-III hormone receptor-positive/HER2-negative breast cancer: A propensity score–matched analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12673